The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...

In severe treatment-resistant depression, long-term data show VNS benefits not only persist for 2 years but also continue to emerge in late responders.

While proven a safe method, external trigeminal nerve stimulation was nonsuperior to sham treatment as early as 4 weeks and as long as 6 months in children and adolescents with ADHD, according to data ...

Find out how vagus nerve stimulation delivers durable symptom relief and quality of life gains in treatment resistant depression patients.

A larger trial of trigeminal nerve stimulation in children with ADHD produce results that differ from an earlier pilot study, raising new questions about its efficacy.

More than 20% of all patients treated with the implant had essentially no symptoms of depression after two years, researchers ...

Research shows that vagus nerve stimulation can provide long-lasting benefits for patients who do not respond to conventional treatments Around 20% of adults in the United States will experience major ...

In 2019, the FDA cleared an external trigeminal nerve stimulation (eTNS) device to treat ADHD symptoms in children ages 7-12 years. In contrast to earlier findings, a new trial in England suggested ...

Researchers report that vagus nerve stimulation helped many people with long-standing, treatment-resistant depression feel ...

They’re known to play a significant role in putting us in a state of rest and digest (as opposed to fight or flight), and ...

By Tarun Sai Lomte Two-year data show that adding VNS to standard care can produce lasting symptom, function, and ...